<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04129242</url>
  </required_header>
  <id_info>
    <org_study_id>00086291</org_study_id>
    <secondary_id>2P20GM109040</secondary_id>
    <nct_id>NCT04129242</nct_id>
  </id_info>
  <brief_title>taVNS for Upper Limb Rehabilitation</brief_title>
  <official_title>Optimization of Closed-loop Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) as a Neurorehabilitation Tool</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of General Medical Sciences (NIGMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study explores the use of a new form of neuromodulation known as transcutaneous&#xD;
      auricular vagus nerve stimulation (taVNS) which stimulates the ear. This stimulation will be&#xD;
      delivered concurrently with upper limb motor rehabilitation training (3 days/week for 4&#xD;
      weeks) in chronic stroke patients. Patients will undergo a series of baseline assessments&#xD;
      (including a brain scan), a 4-week course of motor rehabilitation, and post-assessments&#xD;
      (including a second brain scan)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to refine and develop closed loop taVNS, establish activity with key&#xD;
      biomarkers, and show initial feasibility in a small clinical trial. For paired taVNS to&#xD;
      succeed as a clinical treatment, it is critical to develop and refine a closed-loop taVNS&#xD;
      platform that delivers stimulation concurrently during specific movements of the motor&#xD;
      rehabilitation training.&#xD;
&#xD;
      Aim 1 develops this novel motion-gated closed-loop system that delivers taVNS in synchrony&#xD;
      with specific upper limb motor activation (n=5) Aim 2 will combine the development of the&#xD;
      closed-loop system with the investigator's mechanistic understanding to explore an open-label&#xD;
      pilot trial (n=20) using closed-loop taVNS paired with task-specific training to determine&#xD;
      the feasibility, safety, and potential effect size of this novel combination therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Fugl-Meyer Assessment of the Upper Extremity</measure>
    <time_frame>Participants will be assessed weekly for the duration of the 4-week intervention, followed by 2 and 8 weeks post intervention.</time_frame>
    <description>The Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) is a stroke rehabilitation assessment of arm/hand movement impairment. It is scored by assigning 30 items assessing voluntary arm/hand movements and 3 items assessing reflexes an ordinal rating (0=unable, 1=partial, 2=near normal), then summing the ratings to obtain a general statement of ability. Possible aggregate scores range from 0/66 to 66/66 points. Higher scores indicate greater levels of arm movement ability.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>&quot;paired&quot; taVNS + Task Specific Training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;unpaired&quot; taVNS + Task Specific Training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training</intervention_name>
    <description>A closed-loop taVNS system that delivers taVNS with upper-limb rehabilitation training in a chronic stroke population.</description>
    <arm_group_label>&quot;paired&quot; taVNS + Task Specific Training</arm_group_label>
    <arm_group_label>&quot;unpaired&quot; taVNS + Task Specific Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-80 years old&#xD;
&#xD;
          -  First-ever ischemic stroke that occurred at least 6 months prior&#xD;
&#xD;
          -  Completed conventional rehabilitation therapy at least one month prior&#xD;
&#xD;
          -  Unilateral limb weakness with Fugl Meyer-Upper Extremity Scale score less than or&#xD;
             equal to 58 (out of 66)&#xD;
&#xD;
          -  Inducible MEPs (Motor Evoked Potentials) by TMS (Transcranial Magnetic Stimulation) on&#xD;
             abductor pollicis brevis (APB) muscle on the paretic limb (intact corticospinal&#xD;
             tract).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary intracerebral hematoma, or subarachnoid hemorrhage&#xD;
&#xD;
          -  Bihemispheric ischemic stroke&#xD;
&#xD;
          -  History of prior stroke or old infarct demonstrated on the CT or MRI or documented in&#xD;
             medical records&#xD;
&#xD;
          -  Other concomitant neurological disorders affecting upper extremity motor function&#xD;
&#xD;
          -  Documented history of dementia before or after stroke&#xD;
&#xD;
          -  Documented history of uncontrolled depression or psychiatric disorder either before or&#xD;
             after stroke which could affect their ability to participate in the experiment&#xD;
&#xD;
          -  Uncontrolled hypertension despite treatment, specifically SBP (Systolic Blood&#xD;
             Pressure) / DBP (Diastolic Blood Pressure) &gt;=180/100mmHg at baseline&#xD;
&#xD;
          -  Contraindicated for MRI scanning.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bashar Badran, PhD</last_name>
    <phone>843-792-6076</phone>
    <email>badran@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrew Fortune, BS</last_name>
    <phone>843-792-8970</phone>
    <email>fortunea@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bashar W Badran, PhD</last_name>
      <email>badran@musc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>September 23, 2019</study_first_submitted>
  <study_first_submitted_qc>October 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2019</study_first_posted>
  <last_update_submitted>May 19, 2021</last_update_submitted>
  <last_update_submitted_qc>May 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Bashar Badran</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Vagus Nerve Stimulation</keyword>
  <keyword>Brain Stimulation</keyword>
  <keyword>Occupational Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

